Pharmacoeconomic research partnerships beneficial to drug companies

1995 ◽  
Vol 31 (1) ◽  
pp. 16-16
Keyword(s):  
Research Partnerships ◽  
Pharmacoeconomic Research ◽  
Drug Companies

Serving the People in Long Beach, California: Advancing Justice for Southeast Asian Youth through Community University Research Partnerships

2019 ◽  
Vol 16 (1-2) ◽  
pp. 1-34
Author(s):  
R. Varisa Patraporn
Keyword(s):  
Asian American ◽  
Research Work ◽  
Community Based Participatory Research ◽  
Youth Empowerment ◽  
Long Beach ◽  
Structured Interviews ◽  
Research Partnerships ◽  
Community Needs ◽  
The People ◽  
The Impact

Khmer Girl’s in Action is a nonprofit that successfully utilizes community-based participatory research (CBPR) with university partners to create social change for youth in Long Beach, CA. Based on semi-structured interviews and content analysis of news articles, I explore the impact and sustainability of this research work and the research partnerships. Findings highlight impacts such as youth empowerment, heightened awareness around community needs, policy change, and CBPR curriculum improvements in the field as impacts. Sustainability requires integrating research into program funding, utilizing a tailored training curriculum, building on community members prior relationships, and selecting partners that share common goals, levels of commitment, and flexibility. As funders demand more data to justify community needs, understanding more examples of such work in the Asian American community will be useful for informing future partnerships.

AIDS Drugs & the Pharmaceutical Industry: A Need For Reform

1991 ◽  
Vol 17 (4) ◽  
pp. 363-410
Author(s):  
Mary T. Griffin
Keyword(s):  
Pharmaceutical Industry ◽  
Research And Development ◽  
Drug Approval ◽  
Hiv And Aids ◽  
Price Regulation ◽  
Drug Industry ◽  
Drug Companies ◽  
Aids Drugs

AbstractThe pharmaceutical industry has long enjoyed substantial profits despite increased requirements for drug approval and various attempts to regulate the industry. Drug companies have avoided effective regulation by blaming high prices on the costs of research and development. The search for drugs effective in combatting HIV and AIDS related illnesses has provided a stark background on which to view the actions and justifications of drug companies. Despite increased cooperation between government and the drug industry and expedited approval of several useful drugs, these drugs are still prohibitively expensive. This Article explores the history and economics of the drug industry and proposes a system of national price regulation for all drugs.

scholarly journals COVID-19 and Children’s Well-Being: A Rapid Research Agenda

2021 ◽  
Author(s):  
Rebecca N. Dudovitz ◽  
Shirley Russ ◽  
Mary Berghaus ◽  
Iheoma U. Iruka ◽  
Jessica DiBari ◽  
...  
Keyword(s):  
Nonprofit Organizations ◽  
Research Agenda ◽  
Well Being ◽  
Research Network ◽  
Negative Effects ◽  
Research Partnerships ◽  
Data Infrastructure ◽  
Community Based Research ◽  
National Measurement ◽  
Resilient Response

Abstract Purpose Understanding the full impact of COVID-19 on U.S. children, families, and communities is critical to (a) document the scope of the problem, (b) identify solutions to mitigate harm, and (c) build more resilient response systems. We sought to develop a research agenda to understand the short- and long-term mechanisms and impacts of the COVID-19 pandemic on children’s healthy development, with the goal of devising and ultimately testing interventions to respond to urgent needs and prepare for future pandemics. Description The Life Course Intervention Research Network facilitated a series of virtual meetings that included members of 10 Maternal and Child Health (MCH) research programs, their research and implementation partners, as well as family and community representatives, to develop an MCH COVID-19 Research Agenda. Stakeholders from academia, clinical practice, nonprofit organizations, and family advocates participated in four meetings, with 30–35 participants at each meeting. Assessment Investigating the impacts of COVID-19 on children’s mental health and ways to address them emerged as the highest research priority, followed by studying resilience at individual and community levels; identifying and mitigating the disparate negative effects of the pandemic on children and families of color, prioritizing community-based research partnerships, and strengthening local, state and national measurement systems to monitor children’s well-being during a national crisis. Conclusion Enacting this research agenda will require engaging the community, especially youth, as equal partners in research co-design processes; centering anti-racist perspectives; adopting a “strengths-based” approach; and integrating young researchers who identify as Black, Indigenous, and People of Color (BIPOC). New collaborative funding models and investments in data infrastructure are also needed.

DRUG COMPANIES AND JOURNAL SUPPLEMENTS

The Lancet ◽  
1986 ◽  
Vol 327 (8490) ◽  
pp. 1157 ◽  
Author(s):  
RobertL. Cohen
Keyword(s):  
Drug Companies

Creating Academic and Health Care Partnerships that Impact Public Health

2015 ◽  
Vol 4 (4) ◽  
pp. 378-384
Author(s):  
Peter W. Grandjean ◽  
Burritt W. Hess ◽  
Nicholas Schwedock ◽  
Jackson O. Griggs ◽  
Paul M. Gordon
Keyword(s):  
Public Health ◽  
Health Care ◽  
Health Care Providers ◽  
Professional Training ◽  
Local Health ◽  
Care Providers ◽  
Research Partnerships ◽  
Local Health Care ◽  
Training Community ◽  
The University

Kinesiology programs are well positioned to create and develop partnerships within the university, with local health care providers, and with the community to integrate and enhance the activities of professional training, community service, public health outreach, and collaborative research. Partnerships with medical and health care organizations may be structured to fulfill accreditation standards and the objectives of the “Exercise is Medicine®” initiative to improve public health through primary prevention. Barriers of scale, location, time, human resources, and funding can be overcome so all stakeholder benefits are much greater than the costs.

Drug Companies Push Into Central Europe

2006 ◽  
Vol 84 (14) ◽  
pp. 16 ◽  
Author(s):  
MICHAEL MCCOY ◽  
JEAN-FRANÇOIS TREMBLAY
Keyword(s):  
Central Europe ◽  
Drug Companies

Feature

2010 ◽  
Vol 14 (05n06) ◽  
pp. 22-38
Keyword(s):  
Cancer Patients ◽  
Biodiversity Conservation ◽  
Mobile Health ◽  
Health Records ◽  
Drug Companies ◽  
A Priority ◽  
Vein Harvesting

Biodiversity Conservation is Everyone's Business. Search for ASEAN Champions of Biodiversity is On. Drug Companies Reduce Prices of Medicines. SWS: Make Health A Priority, Filipinos Ask Next Leaders. New Vein Harvesting Technology. Mobile Health Records in Malaysia. Faster, Accurately Targeted Radiation Cancer Patients. SingHealth Selects IBM and SAP To Transform HR Processes.

Sign in / Sign up

Export Citation Format

Share Document